Nicandro Durante - Reckitt Benckiser Independent Non-Executive Director
| RBGLY Stock | USD 12.42 0.13 1.04% |
Director
Mr. Nicandro Durante serves as Independent NonExecutive Director of the Company effective December 1, 2013. He joined the RB Board in December 2013. He holds degrees in Finance, Economics and Business Administration. He started his career working in finance in Brazil and joined British American Tobacco in 1981. Whilst at BAT he has worked in the UK, Hong Kong and Brazil. He held senior positions, including Regional Director for Africa and the Middle East, and was appointed as Chief Operating Officer prior to his current appointment. He was Chief Executive Officer of British American Tobacco p.l.c. since March 2011. since 2013.
| Age | 67 |
| Tenure | 11 years |
| Phone | 44 17 5321 7800 |
| Web | https://www.reckitt.com |
Reckitt Benckiser Management Efficiency
The company has return on total asset (ROA) of 0.0681 % which means that it generated a profit of $0.0681 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3931 %, meaning that it generated $0.3931 on every $100 dollars invested by stockholders. Reckitt Benckiser's management efficiency ratios could be used to measure how well Reckitt Benckiser manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Amy Banse | The Clorox | 61 | |
| Feike Sijbesma | Unilever PLC ADR | 62 | |
| Laura Nathanson | Nu Skin Enterprises | 62 | |
| Robert Decherd | Kimberly Clark | 69 | |
| Abelardo Bru | Kimberly Clark | 70 | |
| Fernando Fernandez | Unilever PLC ADR | 58 | |
| Spencer Fleischer | The Clorox | 67 | |
| John Culver | Kimberly Clark | 60 | |
| Laura Cha | Unilever PLC ADR | 71 | |
| Robert Matschullat | The Clorox | 71 | |
| Pamela ThomasGraham | The Clorox | 57 | |
| Graeme Pitkethly | Unilever PLC ADR | 58 | |
| Christopher Williams | The Clorox | 63 | |
| John Cahill | Colgate Palmolive | 63 | |
| Bradley Irwin | Church Dwight | 62 | |
| Allan Mackay | The Clorox | 65 | |
| Stephen Sadove | Colgate Palmolive | 69 | |
| Richard Carmona | The Clorox | 71 | |
| Rose Bravo | Estee Lauder Companies | 69 | |
| Sherilyn McCoy | Kimberly Clark | 62 | |
| Ian Read | Kimberly Clark | 66 | |
Management Performance
| Return On Equity | 0.39 | |||
| Return On Asset | 0.0681 |
Reckitt Benckiser Leadership Team
Elected by the shareholders, the Reckitt Benckiser's board of directors comprises two types of representatives: Reckitt Benckiser inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Reckitt. The board's role is to monitor Reckitt Benckiser's management team and ensure that shareholders' interests are well served. Reckitt Benckiser's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Reckitt Benckiser's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sami Naffakh, Chief Officer | ||
| Filippo Catalano, Chief Officer | ||
| Fabrice Beaulieu, Sustainability Marketing | ||
| Ranjay Radhakrishnan, Chief Officer | ||
| Kris Licht, Pres Officer | ||
| Nicandro Durante, Independent Non-Executive Director | ||
| Richard Joyce, Sr. VP of Investor Relations, Communications and External Affairs | ||
| John Dawson, VP Relations | ||
| BEng ACMA, Group Director | ||
| Catheryn ORourke, Gen VP |
Reckitt Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Reckitt Benckiser a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.39 | |||
| Return On Asset | 0.0681 | |||
| Profit Margin | 0.22 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 61.62 B | |||
| Shares Outstanding | 3.58 B | |||
| Shares Owned By Institutions | 1.63 % | |||
| Price To Earning | 31.16 X | |||
| Price To Book | 4.76 X | |||
| Price To Sales | 3.74 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Reckitt Pink Sheet Analysis
When running Reckitt Benckiser's price analysis, check to measure Reckitt Benckiser's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reckitt Benckiser is operating at the current time. Most of Reckitt Benckiser's value examination focuses on studying past and present price action to predict the probability of Reckitt Benckiser's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reckitt Benckiser's price. Additionally, you may evaluate how the addition of Reckitt Benckiser to your portfolios can decrease your overall portfolio volatility.